The Effect of Horizant (Gabapentin Enacarbil) on Augmentation
Status:
Completed
Trial end date:
2019-05-06
Target enrollment:
Participant gender:
Summary
Restless Legs Syndrome (RLS) is a common neurological disorder. Augmentation is the main
complication during long-term DA treatment of RLS. This study aims to examine effect of
Horizant (Gabapentin Enacarbil) on Augmentation in RLS patients.